vimarsana.com
Home
Live Updates
Is there a difference in the risk of hospital admission betw
Is there a difference in the risk of hospital admission betw
Is there a difference in the risk of hospital admission between BA.1 and BA.2 cases treated with Sotrovimab?
Researchers compared the risk associated with hospitalization of sotrovimab-treated individuals infected with SARS-CoV-2 Omicron variants.
Related Keywords
United Kingdom ,
London ,
City Of ,
,
United Kingdom Health Security Agency ,
Digital Secondary Uses Service ,
National Health Service ,
Image Credit ,
Secondary Uses Service ,
Emergency Care Data Set ,
Coronavirus Disease Covid 19 ,
Hospital ,
Otrovimab ,
Coronavirus ,
Covid 19 ,
Efficacy ,
Gene ,
N Vitro ,
Micron ,
Protein ,
Espiratory ,
Cars ,
Ars Cov 2 ,
Evere Acute Respiratory ,
Evere Acute Respiratory Syndrome ,
Spike Protein ,
Yndrome ,